Share Price:

APNASPENAspen Pharmacare Hldgs9894210 (2.17%)

Aspen establishes its international platform for future growth

Johannesburg – JSE listed Aspen Pharmacare Holdings Limited, Africaโ€™s largest pharmaceutical manufacturer, is pleased to announce positive results for the year ended 30 June 2008. The Group delivered sustained growth from its existing bases in South Africa, Australia and Asia. A series of significant transactions were concluded to expand the Groupโ€™s footprint into Latin America,… Continue reading Aspen establishes its international platform for future growth

Revision of Terms of Aspen`s Investment in Strides` Latin American Operations

Further to the announcement made on 20 November 2007, Aspen is pleased to announce that its wholly owned subsidiary, Aspen Global Incorporated (โ€œGlobalโ€) has agreed revised terms with Strides Arcolab Limited (โ€œStridesโ€), a pharmaceutical company registered in the Republic of India, in respect of certain aspects of Globalโ€™s acquisition of an interest in Stridesโ€™ Latin… Continue reading Revision of Terms of Aspen`s Investment in Strides` Latin American Operations

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.